Teresa Morán
Universitat Autònoma de Barcelona(ES)Institut Català d'Oncologia(ES)Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(ES)Hospital Universitari Germans Trias i Pujol(ES)Spanish Ovarian Cancer Research Group(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial(2012)5,500 cited
- → Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer(2009)2,363 cited
- → EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis(2016)1,214 cited
- → RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer(2015)626 cited
- → Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer(2013)555 cited
- → Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor gene mutations but lack mutations in or